Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

被引：0
|
作者：
Jia Peng
Ming-Ming Liu
Jing-Lu Jin
Ye-Xuan Cao
Yuan-Lin Guo
Na-Qiong Wu
Cheng-Gang Zhu
Qian Dong
Jing Sun
Rui-Xia Xu
Jian-Jun Li
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Cardiovascular Diseases, Fu Wai Hospital, National Center for Cardiovascular Diseases
来源：
Cardiovascular Diabetology | / 19卷
关键词：
PCSK9; DM; CAD; Maces; Cardiovascular metabolic markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus
    Huang, Juan
    Gu, Jun-Xu
    Wang, Kun
    Zhang, Ai-Min
    Hong, Ting-Ting
    Li, Shan-Shan
    Yao, Xiao-Qin
    Yang, Ming
    Yin, Yue
    Zhang, Na
    Su, Ming
    Hu, Jia-Jia
    Zhang, Xue-Zhi
    Jia, Mei
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [32] Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus
    Juan Huang
    Jun-Xu Gu
    Kun Wang
    Ai-Min Zhang
    Ting-Ting Hong
    Shan-Shan Li
    Xiao-Qin Yao
    Ming Yang
    Yue Yin
    Na Zhang
    Ming Su
    Jia-Jia Hu
    Xue-Zhi Zhang
    Mei Jia
    Diabetology & Metabolic Syndrome, 15
  • [33] Obesity With and Without Metabolic Syndrome - Association With Coronary Artery Disease and Adverse Cardiovascular Outcomes
    Hulten, Edward
    Bittencourt, Marcio
    Ghoshhajra, Brian
    Shah, Ravi
    Abbasi, Siddique
    Abbara, Suhny
    Nasir, Khurram
    Blaha, Michael
    Hoffmann, Udo
    Di Carli, Marcelo F.
    Blankstein, Ron
    CIRCULATION, 2014, 130
  • [34] ASSOCIATION OF LIPOPROTEIN(A) AND FIBRINOGEN AS PROGNOSTIC PREDICTORS FOR CARDIOVASCULAR OUTCOME IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: A PROSPECTIVE, LARGE COHORT STUDY
    Zhang, Yan
    Jin, Jing-Lu
    Cao, Ye-Xuan
    Liu, Hui-Hui
    Zhang, Hui-Wen
    Xu, Rui-Xia
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Ying, Gao
    Cui, Chuan-Jue
    Geng, Liu
    Dong, Qian
    Sun, Jing
    Li, Jian-Jun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 200 - 200
  • [35] PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease
    Acena, Alvaro
    Franco Pelaez, Juan Antonio
    Pello Lazaro, Ana Maria
    Gonzalez Parra, Emilio
    Gonzalez Lorenzo, Oscar
    Martinez-Mina, Juan
    Hernandez, Ignacio
    Luisa Martin-Mariscal, Maria
    Lopez Castillo, Marta
    Kallmeyer, Andrea
    Lorenzo, Oscar
    Luisa Gonzalez-Casaus, Maria
    Egido, Jesus
    Tunon, Jose
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2021, 14 (02) : 238 - 245
  • [36] PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease
    Álvaro Aceña
    Juan Antonio Franco Peláez
    Ana María Pello Lázaro
    Emilio Gonzalez Parra
    Óscar Gonzalez Lorenzo
    Juan Martínez-Milla
    Ignacio Hernandez
    María Luisa Martín-Mariscal
    Marta Lopez Castillo
    Andrea Kallmeyer
    Oscar Lorenzo
    María Luisa González-Casaus
    Jesús Egido
    José Tuñón
    Journal of Cardiovascular Translational Research, 2021, 14 : 238 - 245
  • [37] Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease A Prospective Observational Cohort Study
    Li, Jian-Jun
    Li, Sha
    Zhang, Yan
    Xu, Rui-Xia
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Wu, Na-Qiong
    Qing, Ping
    Gao, Ying
    Sun, Jing
    Liu, Geng
    Dong, Qian
    MEDICINE, 2015, 94 (52)
  • [38] Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease A Factorial Mendelian Randomization Study
    Cupido, Arjen J.
    Reeskamp, Laurens F.
    Hingorani, Aroon D.
    Finan, Chris
    Asselbergs, Folkert W.
    Hovingh, G. Kees
    Schmidt, Amand F.
    JAMA CARDIOLOGY, 2022, 7 (09) : 955 - 964
  • [39] Eligibility for treatment with PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximum hypolipidaemic therapy
    Rallidis, Loukianos S.
    Triantafyllis, Andreas S.
    HELLENIC JOURNAL OF CARDIOLOGY, 2018, 59 (05) : 293 - 295
  • [40] Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study
    Yuanlu Shu
    Ziwei Deng
    Ye Deng
    Jianliang Zhou
    Jin Wang
    Zhenxing Duan
    Tao Jiang
    Xiang Zhao
    Zhihua Shi
    Chengfeng Qiu
    BMC Emergency Medicine, 23
12345